SCHEMBL4097192

SCHEMBL4097192

COC(=O)C(N)Cc1ccc(Oc2ccc([N+](=O)[O-])cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
MAPT P10636 3/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
MAPK1 P28482 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MYOC Q99972 1/20 0.49
MAOB P27338 1/20 0.47
GAA P10253 2/20 0.46
PTGS2 P35354 1/20 0.46
MMP2 P08253 2/20 0.46
HTR2A P28223 1/20 0.45
DPP4 P27487 1/20 0.45
DPP8 Q6V1X1 1/20 0.45
DPP9 Q86TI2 1/20 0.45
DPP7 Q9UHL4 1/20 0.45
SRD5A2 P31213 1/20 0.45
MMP13 P45452 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8211198 1.00 ALDH1A1 (0.56) ALDH1A1KMT2AMEN1MAPTRAB9A
SCHEMBL4367409 0.93 ALDH1A1 (0.62) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL3317059 0.93 ALDH1A1 (0.62) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL240405 0.93 ALDH1A1 (0.62) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL27546222 0.92 ALDH1A1 (0.61) ALDH1A1KMT2AMEN1RAB9ANPC1
Hydrochloric Acid SCHEMBL4371678 0.92 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1RAB9ANPC1
Hydrochloric Acid SCHEMBL1230535 0.92 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1RAB9ANPC1
Hydrochloric Acid SCHEMBL240404 0.92 ALDH1A1 (0.64) ALDH1A1KMT2AMEN1RAB9ANPC1
SCHEMBL13902136 0.84 RAB9A (0.59) ALDH1A1KMT2AMEN1MAPTRAB9A
SCHEMBL6921335 0.82 GAA (0.57) ALDH1A1KMT2AMAPTRAB9AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-03-26 US disclosed
WO-2008029217-A2 DIPEPTIDYL PEPTIDASE IV INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2008-03-13 WO disclosed
EP-1883629-A2 NOVEL HETEROCYCLIC DERIVATIVES Orchid Research Laboratories Limited (IN) 2008-02-06 EP disclosed
WO-2006123229-A2 NOVEL HETEROCYCLIC DERIVATIVES ORCHID RESEARCH LABORATORIES LIMITED (IN) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082408-A1 NOVEL HETEROCYCLIC DERIVATIVES CYP3A5, CYP3A7, UGT2B7 ALDH1A1 281/4885KMT2A 4164/4885MEN1 454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.